[年轻患者的轻度后COVID综合征]
G S Ivchenko1, N N Lobzhanidze1, D S Rusina1
1North-Caucasus Federal University.
Terapevticheskii arkhiv
|December 30, 2023
概括
后COVID综合征可能会导致由于肝损伤和高血的认知问题. 用L-ornithine-L-aspartate治疗改善了年轻成年人的认知功能和肝酶.
科学领域:
- 神经学 神经学
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
背景情况:
- 后COVID综合征影响生活质量,认知障碍是一个重大问题.
- 由于COVID-19引起的肝损伤或其治疗可能导致高氨血,导致认知障碍,如最小的肝脑病变.
研究的目的:
- 为了研究后COVID综合征的认知障碍.
- 评估L-ornithine-L-aspartate在治疗这些认知障碍中的疗效.
主要方法:
- 研究包括30名学生 (18-24岁) 患有COVID后的认知缺陷和高血.
- 患者接受L-ornithine-L-aspartate治疗,以解决氨水平和肝脏脑病变的症状.
- 监测认知功能,肝酶 (ALT,AST,GT) 和氨水平.
主要成果:
- 用L-ornithine-L-aspartate治疗导致客观发现和肝酶的改善.
- 观察到血液氨水平显著下降.
- 心理测试结果表明认知功能有所改善.
结论:
- 甲酸L-aspartate有效地改善了与后COVID综合征相关的认知障碍.
- 治疗有助于纠正高氨血和相关的肝脏脑病变.
- 这表明了长期COVID-19恢复的潜在治疗策略.
相关概念视频
Acute Pharyngitis
696
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
696
COPD: Pathogenesis and Clinical Features
279
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
279
Pneumonia II: Pathophysiology
279
The pathophysiology of pneumonia involves the following steps:
279
Pleural Effusion II: Symptoms and Management
181
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
181
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Tonsillitis II: Management
114
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
114


